RECRUITING

Bone Stimulator for Spondylolysis

Description

This prospective study aims to investigate the effectiveness of bone stimulator therapy as adjunct treatment of spondylolysis in athletic populations. By evaluating its impact on pain reduction, functional improvement, osseous bony union and return-to-sport time, the investigators seek to provide valuable insights into the role of bone stimulation therapy as a potential treatment modality for this challenging condition.

Study Overview

Study Details

Study overview

This prospective study aims to investigate the effectiveness of bone stimulator therapy as adjunct treatment of spondylolysis in athletic populations. By evaluating its impact on pain reduction, functional improvement, osseous bony union and return-to-sport time, the investigators seek to provide valuable insights into the role of bone stimulation therapy as a potential treatment modality for this challenging condition.

The Efficacy of Bone Stimulator in Treatment and Return-to-Sport for Spondylolysis

Bone Stimulator for Spondylolysis

Condition
Spondylolysis
Intervention / Treatment

-

Contacts and Locations

Houston

Houston Methodist Hospital, Houston, Texas, United States, 77030

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients between the ages of 16 to 40 years of age diagnosed with symptomatic spondylolysis by one of the investigators
  • * Patients who plan to attend prescribed physical therapy
  • * Patients who participate in a regular sport whether that be professional, collegiate or recreational
  • * Any condition which in the investigator's opinion, would interfere with the subject's ability to comply with study instructions
  • * Patients with contraindications to bone stimulator therapy
  • * Patients with pacemaker and implantable cardioverter defibrillator
  • * Patients with previous spine surgery
  • * Patients with metabolic bone conditions
  • * Patients who use nicotine products
  • * Vulnerable populations
  • * Non-English speaking services

Ages Eligible for Study

16 Years to 40 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

The Methodist Hospital Research Institute,

Mark Prasarn, MD, PRINCIPAL_INVESTIGATOR, The Methodist Hospital Research Institute

Study Record Dates

2029-12